Completed PHASE4 INTERVENTIONAL NCT00160849

Lopinavir/r Monotherapy as Maintenance Therapy After Long Term Viral Suppression

Study on the Feasibility of Antiretroviral Therapy With a Single Agent - Lopinavir/r - in Patients Treated With HAART and With Viral Load Below 80 Copies/Ml

Sponsor: Universidade Federal do Rio de Janeiro

Conditions HIV Infections

Interventions Lopinavir/r

Updated 5 times since 2017 Last updated: Oct 19, 2005 Started: Aug 31, 2004 Completion: Mar 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on HIV Infections, this trial is completed. The trial is conducted by Universidade Federal do Rio de Janeiro and has accumulated 5 data snapshots since 2004. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Aug 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Universidade Federal do Rio de Janeiro

Data source: Universidade Federal do Rio de Janeiro

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nova Iguaçu, Brazil
• Rio de Janeiro, Brazil